However, the expression of IFT52 and IFT81 was upregulated in the breast cancer cells, and the expression of IFT88 showed an undetectable difference between HBL-100 and MCF-7 cells (Figure 1B and Supplementary Figures 1B–D). This evidence concerns the gene IFT88 and breast carcinoma.